IRadimed Corp

IRadimed Corp(IRMD)資訊與事件

$87.070

+0.070 (+0.08%)收盤時

IRMD 資訊

IRMD 事件

5/1 08:40

Company Reaffirms FY26 Revenue Guidance of $91M to $96M

Backs FY26 revenue view $91M-$96M, consensus $92.28M. "We reaffirm our guidance for the full-year 2026 with revenue of $91.0 million to $96.0 million, and GAAP diluted earnings per share of $1.90 to $2.05 and non-GAAP diluted earnings per share of $2.06 to $2.21," added Susi.

5/1 08:40

Sees Q2 Revenue of $20M-$21M for 2026

Sees Q2 revenue $20M-$21M, consensus $21.13M. "Looking ahead, for the second quarter of 2026 financial guidance, we expect revenue of $20.0 million to $21.0 million, GAAP diluted earnings per share of $0.40 to $0.44, and non-GAAP diluted earnings per share of $0.44 to $0.48."

5/1 08:40

Company Reports Q1 Revenue of $21.98M, Beating Consensus

Reports Q1 revenue $21.98M, consensus $21.32M. "We are pleased to report a strong start to 2026, with first-quarter revenue of $22.0 million, a 13% increase over the same period last year. Our continued revenue growth, combined with disciplined expense management, drove operating income of $7.2 million - a 33% improvement over the first quarter of 2025 - and net income of $5.8 million, or $0.45 per diluted share, a 22% increase over the first quarter 2025."

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始